News & Events



February 23, 2022

Insights by Stanford Business: QA Plan to Inject More Funding into the War on Antibiotic Resistance

MCiM’s Kevin Schulman and MD/MBA candidate Neil Ghandi propose federal subsidies to accelerate R&D on urgently needed antibiotics.

Read More Here

October 12, 2020

SCOPE Blog: Q/A with MCiM Faculty Director "Investigating the generic drug industry and the health care business model"

MCiM Faculty Director and health economist Kevin Schulman unpacks the complicated workings of the U.S. health system and the generic drug industry. 

Read More Here

September 3, 2020

Stanford Medicine Announces MCiM Launch

The School of Medicine annoucned the launching MCiM, a yearlong master’s program for medical and other professionals who want to improve health care with management skills and technology.

Read More Here

September 1, 2020

SCOPE Blog: Faculty Director Vision for MCiM

As a health services researcher and health economist,  MCiM Faculty Director Kevin Schulman has made it his mission to reduce the cost of great care. He has taught and created education programs around innovation in health care. Stanford’s MCiM is now the first master’s degree program on the West Coast focused on medicine, business, and technology. 

Read More Here